VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
XLO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
XLOXilio Therapeutics, Inc.
$9.01$175M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksXLOQuarterly Balance Sheet

Xilio Therapeutics, Inc. (XLO) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Xilio Therapeutics, Inc. (XLO) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

XLO Balance Sheet

Quarterly statement

XLO Balance Sheet

Xilio Therapeutics, Inc. (XLO) balance sheet — 7-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets145.47M154.21M145.03M124.09M123.72M93.2M60.23M63.31M78.01M69.19M48.13M64.48M78.42M96.98M124.5M142.31M163.01M181.09M202.52M105.57M
Cash & Short-Term Investments136.04M150.33M137.53M103.76M121.55M89.07M55.29M61.26M74.95M33.98M44.7M59.77M75.38M93.27M120.39M139.14M159.41M176.96M198.05M99.77M
Cash Only136.04M150.33M137.53M103.76M121.55M89.07M55.29M61.26M74.95M33.98M44.7M59.77M75.38M93.27M120.39M139.14M159.41M176.96M198.05M99.77M
Short-Term Investments00000000000000000000
Accounts Receivable6M05M00000030M0000000000
Days Sales Outstanding29.21-33.61-----------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets03.87M2.5M20.32M2.17M4.13M4.94M2.05M05.21M3.42M03.04M04.11M3.17M04.13M4.46M3.4M
Total Non-Current Assets8.79M9.28M9.66M9.61M10.1M10.52M10.84M11.35M11.87M13.42M12.8M13.36M13.93M14.53M14.67M15.1M15.12M15.27M19.08M15.15M
Property, Plant & Equipment6.97M7.47M7.85M7.8M8.3M8.73M9.06M9.57M10M10.54M11.2M11.61M12.16M12.73M12.84M13.24M13.23M13.35M13.9M13.17M
Fixed Asset Turnover2.59x1.65x1.75x2.37x0.95x0.33x0.19x0.23x0.23x-----------
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments001.81M01.79M1.79M1.78M1.77M02.76M00001.56M1.56M01.55M1.55M0
Other Non-Current Assets1.82M1.81M01.8M00001.86M121K1.6M1.75M1.77M1.8M267K301K1.89M359K90K1.98M
Total Assets154.25M163.49M154.69M133.69M133.81M103.72M71.08M74.66M89.87M82.61M60.93M77.84M92.36M111.5M139.16M157.41M178.13M196.35M221.6M120.72M
Asset Turnover0.12x0.08x0.09x0.14x0.07x0.03x0.02x0.03x0.03x-----------
Asset Growth %15.28%57.63%117.64%79.08%48.89%25.55%16.66%-4.09%-2.69%-25.91%-56.22%-50.55%-48.15%-43.21%-37.2%30.39%27.21%24%510.18%-
Total Current Liabilities34.2M42.96M56.27M56.4M53.26M47.64M27.26M38.02M38.64M31.58M15.96M16.93M16.29M16.19M21.12M16.84M17.77M12.22M12.78M12.87M
Accounts Payable2.31M1.06M3.17M2.3M4.1M2.27M2.57M972K1.26M746K1.05M1.49M945K2.01M3.13M1.81M1.41M2.32M3.14M3.82M
Days Payables Outstanding-553.6--18.91-----259.81-273.55-------
Short-Term Debt00000000003.31M4.96M7.14M6.67M6.67M5.89M3.33M2.5M883K0
Deferred Revenue (Current)22.6M31.54M40.02M43.85M42.28M40.25M13.52M26.11M26.52M21.73M0000000000
Other Current Liabilities01.7M5.73M4.19M2.66M1.43M4.21M3.36M2.52M6.67M6.9M082K82K82K4.53M82K5.09M3.61M82K
Current Ratio4.25x3.59x2.58x2.20x2.32x1.96x2.21x1.67x2.02x2.19x3.02x3.81x4.81x5.99x5.89x8.45x9.17x14.81x15.85x8.20x
Quick Ratio4.25x3.59x2.58x2.20x2.32x1.96x2.21x1.67x2.02x2.19x3.02x3.81x4.81x5.99x5.89x8.45x9.17x14.81x15.85x8.20x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities47.79M47.98M63.14M85.39M73.48M45.38M26.22M15.66M17.82M25.26M8.14M8.41M8.69M10.52M12.4M14.27M16.14M18.01M23.39M244.31M
Long-Term Debt05.25M000000000001.55M3.17M4.78M6.39M8.01M9.63M9.58M
Capital Lease Obligations4.88M05.61M5.96M6.3M6.64M6.95M7.26M7.57M7.86M8.14M8.41M8.68M8.95M9.19M9.43M9.66M9.89M10.22M10.32M
Deferred Tax Liabilities0000000000000000003.54M0
Other Non-Current Liabilities30.2M42.73M36.89M53.93M38.55M00010.25M0007K26K45K64K82K100K0224.41M
Total Liabilities81.99M90.94M119.41M141.79M126.74M93.02M53.48M53.68M56.46M56.84M24.1M25.34M24.98M26.71M33.52M31.12M33.91M30.23M36.17M257.18M
Total Debt6.3M6.64M6.95M7.26M7.57M7.86M8.14M8.41M8.68M8.94M11.46M14.45M16.81M18.11M19.94M20.99M20.25M21.23M20.74M20.67M
Net Debt-129.74M-143.69M-130.58M-96.5M-113.98M-81.21M-47.15M-52.84M-66.27M-25.04M-33.25M-45.32M-58.58M-75.16M-100.45M-118.16M-139.16M-155.73M-177.32M-79.1M
Debt / Equity0.09x0.09x0.20x-1.07x0.73x0.46x0.40x0.26x0.35x0.31x0.28x0.25x0.21x0.19x0.17x0.14x0.13x0.11x-
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-----------175.55x-86.81x-95.78x-----164.53x--
Total Equity72.26M72.55M35.27M-8.1M7.07M10.7M17.6M20.97M33.42M25.77M36.83M52.5M67.38M84.79M105.65M126.3M144.22M166.12M185.43M-136.46M
Equity Growth %922.27%577.99%100.44%-138.6%-78.85%-58.47%-52.21%-60.05%-50.4%-69.61%-65.14%-58.43%-53.28%-48.96%-43.03%192.56%41.98%34.24%3608.59%-
Book Value per Share3.720.440.42-0.791.912.013.814.6310.6412.9218.7126.7034.3443.2753.9564.5373.7384.98129.43-2500.91
Total Shareholders' Equity72.26M72.55M35.27M-8.1M7.07M10.7M17.6M20.97M33.42M25.77M36.83M52.5M67.38M84.79M105.65M126.3M144.22M166.12M185.43M-136.46M
Common Stock1K1K36.89M53.94M5K5K5K4K4K3K3K3K3K3K3K3K3K3K3K0
Retained Earnings-434.69M-428.32M-418.79M-429.15M-412.86M-397.02M-383.75M-370.66M-356.64M-342.71M-325.51M-307.86M-291.11M-271.75M-249.11M-226.64M-206.85M-182.24M-160.89M-141.19M
Treasury Stock00000000000000000000
Accumulated OCI00000000000000000000
Minority Interest00000000000000000000